Search results for "ANGIOPLASTY"

showing 10 items of 201 documents

Analysis of risk factors for restenosis after PTCA

1990

To identify risk factors for restenosis, we evaluated data in 473 patients with single-vessel percutaneous transluminal coronary angioplasty (PTCA) and control angiography after 6 months. Restenosis, defined as (1) loss greater than 50% of the initial gain, and (2) stenosis greater than 50% was found in 138 patients (29.2%). Univariate analysis revealed eight factors related to restenosis: (1) duration of symptoms less than 1 month (P = 0.005), (2) unstable angina (P = 0.004), (3) high-grade stenosis before PTCA (P = 0.014), (4) large residual stenosis after PTCA (P = 0.001), (5) insufficient improvement of stenosis (P = 0.042), (6) prolonged single inflation time (P = 0.017), (7) prolonged…

Malemedicine.medical_specialtyPercutaneous transluminal coronary angioplastyCoronary DiseaseCoronary AngiographyRestenosisRecurrenceRisk FactorsInternal medicinemedicineHumansAngina Unstablecardiovascular diseasesAngioplasty Balloon CoronaryAgedAnalysis of VarianceUnivariate analysismedicine.diagnostic_testbusiness.industryUnstable anginaResidual stenosisMiddle Agedmedicine.diseaseCoronary VesselsStenosisAngiographyCardiologyEvaluated dataCardiology and Cardiovascular MedicinebusinessCatheterization and Cardiovascular Diagnosis
researchProduct

Influence of vessel dilatation on restenosis after successful percutaneous transluminal coronary angioplasty.

1996

The aim of this study was to evaluate the influence of vessel dilation on restenosis after successful percutaneous transluminal coronary angioplasty (PTCA) on the basis of quantitative angiographic analysis. To have the best comparison possible, we restrospectively studied a homogenous series of patients from the early 1980s treated according to a standardized PTCA procedure. The study group consisted of 86 patients with stable angina pectoris and single-vessel disease, all of whom underwent successful PTCA for a short concentric lesion in proximal vessel parts. The overall restenosis rate was 27%. Angiographically measured balloon size remained below specifications. The size of the inflate…

Malemedicine.medical_specialtyPercutaneous transluminal coronary angioplastyLumen (anatomy)Coronary DiseaseBalloonLesionRestenosisRecurrenceInternal medicinemedicineHumansIn patientAngioplasty Balloon CoronaryAgedbusiness.industryMiddle Agedmedicine.diseaseVessel diameterTreatment OutcomeCardiologyFemalemedicine.symptomCardiology and Cardiovascular MedicineComplicationbusinessAmerican heart journal
researchProduct

Combination of high bolus dose of tirofiban with half dose thrombolytics for the treatment of subacute stent thrombosis

2005

Acute stent thrombosis is rare and it is usually related to complications during the procedure. Subacute thrombosis is far more common and is associated with a high incidence of acute myocardial infarction and death. Restoration of flow by thrombolysis, emergency bypass surgery or emergency percutaneous transluminal coronary angioplasty (PTCA) has had only limited success with respect to myocardial salvage. We report the case of a patient who suffered from recurrent subacute stent thrombosis, in whom administration of tirofiban at high-dose bolus in association with a half dose of recombinant tissue plasminogen activator succeeded in restoring normal myocardial flow and stable clinical cond…

Malemedicine.medical_specialtyPercutaneous transluminal coronary angioplastymedicine.medical_treatmentMyocardial InfarctionThrombolysiCoronary AngiographyRisk AssessmentBolus (medicine)Fibrinolytic AgentsCoronary CirculationAcute thrombosiInternal medicineStentmedicineHumanscardiovascular diseasesStent thrombosisMyocardial infarctionAngioplasty Balloon CoronaryVascular PatencyAgedDose-Response Relationship Drugbusiness.industryCoronary ThrombosisGeneral MedicineTirofibanThrombolysismedicine.diseaseThrombosisSurgeryTirofibanBypass surgeryAcute DiseaseCardiologyTyrosineDrug Therapy CombinationStentsCardiology and Cardiovascular MedicinebusinessFollow-Up Studiesmedicine.drugActa Cardiologica
researchProduct

Recanalization of complex coronary chronic total occlusions using high-frequency vibrational energy CROSSER catheter as first-line therapy: A single …

2010

Background: Several studies have illustrated the safety and the procedural outcome of high-frequency vibrational energy in guidewire refractory chronic total occlusions (CTOs). Aim: To evaluate the advantage of high-frequency vibrational energy device (CROSSER Catheter) use in coronary complex CTO revascularization as primary strategy. Methods: CROSSER was used as a primary approach if four or more unfavorable angiographic features were observed in the CTO lesions. Results: From May 2007 to February 2009, a CTO percutaneous intervention attempt was performed in 178 lesions of 171 patients (60.1 ± 8.9 age with 49.4 ± 7.2% in ejection fraction). Among these, the CROSSER was used in 46 complex…

Malemedicine.medical_specialtyPercutaneousTime Factorsmedicine.medical_treatmentPerforation (oil well)Contrast MediaRevascularizationVibrationCatheterizationMedicineHumansRadiology Nuclear Medicine and imagingMyocardial infarctionAngioplasty Balloon CoronaryAgedEjection fractionDose-Response Relationship Drugbusiness.industryPercutaneous coronary interventionEquipment DesignRecanalizationMiddle Agedmedicine.diseaseCROSSER.SurgeryCatheterCTOTreatment OutcomeCoronary OcclusionFluoroscopyChronic DiseaseFemaleCardiology and Cardiovascular MedicinebusinessMace
researchProduct

A novel 3-d reconstruction system for the assessment of bifurcation lesions treated by the mini-crush technique.

2010

Background: Conventional two-dimensional angiography lacks the ability to properly image the true bifurcation geometry, and its percutaneous coronary intervention-induced changes in the clinical setting. Methods and Results: A novel three-dimensional reconstruction system was investigated by retrospectively analyzing 39 lesions in 35 consecutive patients with coronary bifurcation disease treated with the mini-crush technique. At baseline, significant correlations were proved between two- and three-dimensional systems in terms of either reference vessel diameter (R 2 = 0.68 and 0.29 for main and side branches, respectively), minimum lumen diameter (R 2 = 0.73 and 0.36), stenosis diameter (R …

Malemedicine.medical_specialtyPercutaneousTime Factorsmedicine.medical_treatmentStatistics as TopicCoronary Artery DiseaseCoronary AngiographyStatistics NonparametricVentricular Function LeftLesionCoronary RestenosisImaging Three-DimensionalmedicineHumansRadiology Nuclear Medicine and imagingAngioplasty Balloon CoronaryCoronary Artery BypassBifurcationRetrospective StudiesAnalysis of Variancemedicine.diagnostic_testMini-Crush Technique.business.industryStentStroke VolumeMiddle Agedmedicine.diseaseCoronary VesselsLumen DiameterVessel diameterStenosisAngiographyBifurcationFemaleRadiologymedicine.symptomCardiology and Cardiovascular MedicinebusinessAlgorithmsSoftwareJournal of interventional cardiology
researchProduct

Cryoplasty versus angioplasty in the treatment of arterial restenosis in an experimental model of atherosclerosis in rabbits

2014

Abstract Cryoplasty may reduce the incidence of post-angioplasty restenosis in peripheral atherosclerotic arteries. Our study is looking to investigate the mid-term effects (4 weeks) of an FDA-approved cryoplasty catheter (PolarCath®, Boston Scientific) compared to a conventional angioplasty catheter using a hypercholesterolemic rabbit model of arterial restenosis based on diet plus vessel injury. Thirty-six normolipidemic, 3-month old male New Zealand White rabbits were used. Balloon angioplasty was performed on left external iliac arteries on day 1. Animals were fed with a hypercholesterolemic diet for 60 days. On day 120, three groups of animals were established: conventional PTA (percut…

Malemedicine.medical_specialtyPercutaneousmedicine.medical_treatmentHypercholesterolemiaCryotherapyConstriction PathologicBalloonCryosurgeryIliac ArteryGeneral Biochemistry Genetics and Molecular BiologyRestenosisInternal medicineAngioplastyAnimalsMedicinebusiness.industryGeneral MedicineModels TheoreticalAtherosclerosismedicine.diseaseStenosisCatheterCryotherapyCardiologyRabbitsTunica IntimaGeneral Agricultural and Biological SciencesbusinessVascular StenosisAngioplasty BalloonCryobiology
researchProduct

Percutaneous angioplasty and stenting of left subclavian artery lesions for the treatment of patients with concomitant vertebral and coronary subclav…

2006

bjective: To evaluate the efficacy of subclavian stenosis percutaneous transfemoral angioplasty (PTA)-treatment in patients with intermittent or complete subclavian steal syndrome (SSS), and coronary-subclavian steal syndrome (C-SSS) after left internal mammary artery-interventricular anterior artery (LIMA-IVA) by pass graft. Methods: We studied 42 patients with coronary subclavian steal syndrome subdivided in two groups; the first group consisted of 15 patients who presented an intermittent vertebral-subclavian steal, while the second group consisted of 27 patients with a complete vertebral-subclavian steal. All patients were treated with angioplasty and stent application and were followed…

Malemedicine.medical_specialtyPercutaneousmedicine.medical_treatmentVertebral arterySubclavian ArteryBalloonSubclavian Steal SyndromeRisk FactorsInternal medicinemedicine.arteryAngioplastymedicineHumansRadiology Nuclear Medicine and imagingcardiovascular diseasesInternal Mammary-Coronary Artery Anastomosishealth care economics and organizationsSubclavian arteryVertebral ArteryAgedChi-Square Distributionmedicine.diagnostic_testbusiness.industryAngiographyUltrasonography DopplerMiddle Agedmedicine.diseaseSurgerybody regionssurgical procedures operativemedicine.anatomical_structureTreatment OutcomePercutaneous angioplasty and stenting of left subclavian artery lesions vertebral and coronary subclavian steal syndrome.Angiographycardiovascular systemCardiologyFemaleStentsCardiology and Cardiovascular MedicinebusinessSubclavian steal syndromeAngioplasty BalloonArteryCardiovascular and interventional radiology
researchProduct

Right ventricular involvement in anterior myocardial infarction: a translational approach.

2010

Aims The aim of the present study was to evaluate the involvement of the right ventricle (RV) in reperfused anterior ST-elevation myocardial infarction (STEMI). Methods and results Left anterior descending (LAD)-perfused area (using thioflavin-S staining after selective infusion in proximal LAD artery, %), infarct size (using triphenyltetrazolium chloride staining, %), and salvaged myocardium (% of LAD-perfused area) in the right and left ventricle (LV) were quantified in a 90-min LAD occlusion 3-day reperfusion model in swine ( n = 8). Additionally, we studied, using cardiovascular magnetic resonance, 20 patients with a first STEMI due to proximal LAD occlusion treated with primary angiopl…

Malemedicine.medical_specialtyPhysiologymedicine.medical_treatmentHeart VentriclesSus scrofaInfarctionMagnetic Resonance Imaging CineVentricular Function LeftTranslational Research BiomedicalCoronary circulationReperfusion therapyPhysiology (medical)Internal medicineAngioplastyCoronary CirculationOcclusionmedicineAnimalsHumanscardiovascular diseasesMyocardial infarctionProspective StudiesAngioplasty Balloon CoronaryAnterior Wall Myocardial InfarctionAgedbusiness.industryMyocardiumMiddle Agedmedicine.diseaseDisease Models Animalmedicine.anatomical_structureTreatment OutcomeVentricleCirculatory systemcardiovascular systemCardiologyVentricular Function RightFemaleAutopsyCardiology and Cardiovascular MedicinebusinessNuclear medicineCardiovascular research
researchProduct

Evaluation of post-myocardial infarction regional and global left ventricular function by monoplane ventriculography: superiority of right versus lef…

1996

OBJECTIVES To study the significance of serial quantitative regional wall motion analysis, volumes, and ejection fraction findings as well as their prognostic implications derived from cineventriculography in 30 degrees right anterior oblique (RAO) projection in comparison with 60 degrees left anterior oblique (LAO) projection in post-myocardial infarction patients. Ventriculographic left ventricular parameters are accepted surrogates of mortality in myocardial infarction. Nowadays, in contrast to a biplanar approach in most institutions and clinical trials, the investigation is reduced to monoplanar ventriculography. However, it is not known whether the relevance of the two established pro…

Malemedicine.medical_specialtyStreptokinaseMyocardial InfarctionInfarctionPost myocardial infarctionVentricular Function LeftInternal medicineMedicineHumansMyocardial infarctionAngioplasty Balloon CoronaryVentricular remodelingProjection (set theory)Ejection fractionbusiness.industryGated Blood-Pool ImagingStroke VolumeGeneral MedicineMiddle Agedmedicine.diseaseThrombosisSurvival AnalysisEvaluation Studies as TopicCardiologyFemaleCardiology and Cardiovascular Medicinebusinessmedicine.drugCoronary artery disease
researchProduct

Thrombolysis with saruplase versus streptokinase in acute myocardial infarction: five-year results of the PRIMI trial.

1999

Abstract Background Short-term safety and efficacy of thrombolysis with saruplase in acute myocardial infarction have been shown in several trials. To assess long-term outcome of patients treated with saruplase or streptokinase for myocardial infarction, a 5-year follow-up of patients included in the Pro-Urokinase in Myocardial Infarction Trial was performed. Methods and Results Follow-up data are available from 8 centers on 255 (92.4%) of 276 included patients. The 5-year mortality rate was comparable with 20.8% of patients in the saruplase group and 16.9% in the streptokinase group (odds ratio 1.29, 95% confidence interval 0.69 to 2.42). In both groups, a considerable number of fatal card…

Malemedicine.medical_specialtyStreptokinasemedicine.medical_treatmentMyocardial InfarctionAnginaCohort StudiesFibrinolytic AgentsRecurrenceAngioplastyInternal medicineMedicineHumansStreptokinaseThrombolytic TherapyMyocardial infarctionAngioplasty Balloon CoronaryCoronary Artery BypassAgedbusiness.industryOdds ratioThrombolysisMiddle Agedmedicine.diseaseSurvival AnalysisUrokinase-Type Plasminogen ActivatorConfidence intervalRecombinant ProteinsCerebrovascular DisordersCardiologySaruplaseFemaleCardiology and Cardiovascular Medicinebusinessmedicine.drugFollow-Up StudiesAmerican heart journal
researchProduct